B Positive National Blood Services -

Form 483 issued February 2, 2026 · Wyoming, Pennsylvania

Inspection
Jan 28 – Feb 2, 2026
Investigator
Michele Gottshall
Observations
3
Pages
3
FEI number
3023715801

In short: On February 2, 2026, FDA issued a Form 483 with 3 observations to B Positive National Blood Services - in Wyoming, Pennsylvania (FEI 3023715801) after an inspection that ran Jan 28 – Feb 2, 2026. The investigator was Michele Gottshall. Most observations concern biologics CGMP.

At a glance

3 of 3 observations on this 483 concern biologics cgmp.

Biologics CGMP3

What FDA observed

Preview: the opening words of each observation
  1. 01

    Records are not made concurrently with the performance of each step in…

  2. 02

    Written standard operating procedures including all steps to be followed in the collection, processing, storage and…

  3. 03

    Failure to use supplies and reagents in a maimer consistent with instructions…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at B Positive National Blood Services -?

FDA listed 3 observations on this Form 483, mostly about biologics CGMP. The opening words of each observation are shown on this page.

Who inspected B Positive National Blood Services -?

Michele Gottshall is named on this Form 483, for the inspection of Jan 28 – Feb 2, 2026. Each investigator has a profile showing what they cite most.

When was B Positive National Blood Services - inspected by FDA?

The inspection ran Jan 28 – Feb 2, 2026, and the Form 483 is dated February 2, 2026.

How do I get the full Form 483 for B Positive National Blood Services -?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free